A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose

Clinical trial NCT02571192 · COMPLETED

Trial details

NCT number: NCT02571192
Sponsor: Mirum Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Alcoholic Steatohepatitis

Start date: 2015-10-01
Primary completion: 2015-10-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.